The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies

A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00706212

Acronym

GS-PET-2008

Enrollment

Registered

2008-06-27

Start date

2008-06-30

Completion date

Unknown

Last updated

2008-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological Malignancies

Brief summary

PET CT is one of the imaging tools that are used for staging of urological malignancies. C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed \ 95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients older then 18 years of age * Full consciousness and awareness * suspected to suffer from urological malignancy and a candidate for a surgical procedur

Exclusion criteria

* known secondary malignancy

Countries

Israel

Contacts

Primary ContactShay Golan, MD

shaygo1@yahoo.com972-50-744-7573

Outcome results